Loading company…
RetiSpec Inc. is a Toronto medical imaging company developing AI retinal imaging to detect Alzheimer's disease markers in the eye.
Founded in 2016 by Eliav Shaked (CEO) and Roy Kirshon (COO) and based in Toronto, Canada, RetiSpec Inc. is a research medical imaging company. Its non-invasive, AI-based solution uses hyperspectral imaging of retinal images captured with existing cameras to detect Alzheimer's disease biomarkers during an eye examination. In July 2024 the company raised USD 10 million in Series A funding led by iGan Partners, with participation from Eli Lilly and Company, Gentex Corporation, Verge HealthTech, University of Minnesota and Topcon Healthcare, among others.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in